CVS Health Sells Omnicare to GenieRx Holdings in $250 Million Deal

CD&R and McKesson to Acquire Option Care Health

October 9, 2026

Healthcare Services

Clayton, Dubilier & Rice (CD&R) and McKesson agreed to acquire Option Care Health in a cash transaction valuing the company at approximately $5.8 billion, with CD&R set to own about 51% and McKesson about 49%. The deal is expected to close in the first half of 2027, subject to shareholder and regulatory approvals; Option Care will remain a separate company under its existing management. The buyers aim to support growth in specialty and complex therapies and expand access to infusion care in lower-cost home and community settings.

OptimizeRx Acquires Medicx Health for $95 million

October 12, 2023

Marketing & Advertising

OptimizeRx Corp. (Nasdaq: OPRX) has signed an agreement to acquire Scottsdale-based Medicx Health (Healthy Offers, Inc.) for $95 million, with certain Medicx managers rolling about $10.5 million into OptimizeRx stock. The acquisition will expand OptimizeRx's omnichannel reach by adding Medicx's patient-focused Micro-Neighborhood Targeting platform and analytics, and is expected to be immediately accretive and to increase consolidated revenue run-rate toward $100 million.

CVS Health to Acquire Oak Street Health for $10.6 Billion

February 8, 2023

Healthcare Services

CVS Health and Oak Street Health have entered into a definitive agreement under which CVS Health will acquire Oak Street Health in an all-cash transaction valued at approximately $10.6 billion ($39 per share). The deal is subject to approval by Oak Street Health stockholders, regulatory approvals, and customary closing conditions, with CVS anticipating closing in 2023.

CareRx Acquires Hogan Pharmacy Partners Ltd.

March 30, 2022

Healthcare Services

CareRx Corporation entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd., a technology-enabled long-term care pharmacy serving about 725 residents in Ontario. The consideration includes C$2.2 million in CareRx common shares and a C$2.2 million vendor take-back note; CareRx expects the deal to close in May 2022 and to be immediately accretive to earnings while extending its technology and service capabilities for seniors' congregate care.

Equistone Partners Europe Acquires Majority Stake in Omnicare

August 14, 2019

Pharmaceuticals

Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.

OmniSYS Acquires Rx-Net (ProfitMax)

June 5, 2019

Healthcare Services

OmniSYS, a Dallas-based pharmacy technology company, acquired Rx-Net and its automated prescription pricing solution ProfitMax to expand its product capabilities for retail pharmacies. Rx-Net manages over $4 billion in annual prescription volume with customers across all 50 states, and key Rx-Net personnel are expected to remain to support integration.